NCT01350102

The Relationship of Hemoglobin A1c and Diabetic Wound Healing

• Status: Terminated
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 2 (actual)
• Sponsor: Susan Hassenbein · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to investigate the relationship of hemoglobin A1c in diabetic wound healing. Additionally, a comparison of two wound dressings, AmeriGel® (Amerx Health Care Corp., Clearwater, FL) and Bacitracin, with and without vitamin C supplementation, will be done to evaluate impact on time to wound closure.

Detailed description

This is a prospective randomized controlled study evaluating the relationship of hemoglobin A1c in diabetic wound healing. Length of time for wound closure will be compared using four treatment options.

Conditions

• Diabetes, Type 1
• Diabetes, Type 2
• Foot Ulcer, Diabetic

Interventions

Type	Name	Description
DRUG	Bacitracin	Participants will be treated with Bacitracin to their wound until 100% wound healing, which may take up to 6 months to achieve.
DRUG	AmeriGel®	Participants will be treated with AmeriGel® to their wound until 100% wound healing, which may take up to 6 months to achieve.
DIETARY_SUPPLEMENT	Vitamin C	Participants will be treated with Vitamin C supplements 1000 mg daily until 100% wound healing, which may take up to 6 months to achieve

Timeline

• Start date: 2012-02-01
• Primary completion: 2014-03-01
• Completion: 2014-03-01
• First posted: 2011-05-09
• Last updated: 2017-12-12
• Results posted: 2017-12-12

Locations

1 site across 1 country: United States